Authors:
GAGNON RF
LECLERC J
YARED K
LIBERMAN AS
KHURANA R
GUIMOND MC
VASILEVSKY M
Citation: Rf. Gagnon et al., SAFE AND EFFECTIVE ANTICOAGULATION WITH ENOXAPARIN DURING HEMODIALYSIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 806-806
Citation: Rf. Gagnon et al., ABSENCE OF SIGNIFICANT ANEMIA IN 2 DIALYSIS PATIENTS WITHOUT ERYTHROPOIETIN TREATMENT AND BLOOD-TRANSFUSIONS - POSSIBLE ROLE OF INSULIN-LIKE GROWTH-FACTOR-I IN THE MAINTENANCE OF ERYTHROPOIESIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1150-1150
Authors:
KHURANA R
GAGNON RF
CIANFLONE K
LECLERC J
VASILEVSKY M
Citation: R. Khurana et al., INTRADIALYTIC CHANGES IN CIRCULATING LIPIDS WITH ANTICOAGULATION BY THE LOW-MOLECULAR-WEIGHT HEPARIN ENOXAPARIN, Journal of the American Society of Nephrology, 6(3), 1995, pp. 494-494
Citation: E. Jonasch et al., INSULIN-LIKE GROWTH-FACTOR-I (IGF-1), IGF1 BINDING-PROTEINS (BP1, BP3) AND ERYTHROPOIETIN (EPO) SERUM LEVELS IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 579-579
Authors:
LAPLANTE LE
ANG AA
BOURGOUIN PA
COHANIM M
HERZENBERG M
MCMURDO M
SAVARD C
SEXTON F
SHAVER CS
SHWARTZ I
LALONDE J
GIBB RA
GIOVANNINI AA
IRVING DW
VASILEVSKY M
FRIED JA
AMIES DR
JAW M
DUNHAM PB
MORSE JWI
PARENT R
JOHNSON TE
LAPOINTE G
DUMAS S
HALPENNY RL
POPOWICH KR
Citation: Le. Laplante et al., ENALAPRIL AND ENALAPRIL-HYDROCHLOROTHIAZIDE IN THE TREATMENT OF ESSENTIAL-HYPERTENSION, Clinical therapeutics, 15(2), 1993, pp. 364-373